Dashboard
Manage Tickers

PDSB PDS Biotechnology Corp

Nasdaq pdsbiotech.com


$ 0.98 $ -0.01 (-1.57 %)    

Friday, 31-Oct-2025 16:21:23 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 0.9351
$ 0.95
$ 0.91 x 10
$ 1.00 x 600
$ 0.90 - $ 0.95
$ 0.85 - $ 3.41
678,205
na
43.61M
$ 2.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-28-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-11-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-18-2021 12-31-2020 10-K
20 11-13-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 05-13-2020 03-31-2020 10-Q
23 03-27-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 02-21-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-01-2018 03-31-2018 10-Q
31 03-01-2018 12-31-2017 10-K
32 11-01-2017 09-30-2017 10-Q
33 08-01-2017 06-30-2017 10-Q
34 05-03-2017 03-31-2017 10-Q
35 03-02-2017 12-31-2016 10-K
36 11-01-2016 09-30-2016 10-Q
37 08-03-2016 06-30-2016 10-Q
38 05-03-2016 03-31-2016 10-Q
39 03-08-2016 12-31-2015 10-K
40 11-06-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

pds-biotechnology-announces-national-cancer-institute-to-present-new-clinical-data-to-highlight-details-from-investigational-immunotherapy-platforms
PDS Biotechnology Announces National Cance...
10/30/2025 12:18:13

PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or the "Company"), a late-stage immunotherapy compa...

pds-biotech-requests-meeting-with-fda-to-explore-expedited-approval-pathway-for-pds0101-in-hpv16-positive-head-and-neck-cancer
PDS Biotech Requests Meeting With FDA To E...
10/29/2025 12:38:00

pds-biotech-reports-295-month-median-overall-survival-in-phase-2-trial-for-advanced-head-and-neck-cancer-says-encouraging-efficacy-signal-observed-in-difficult-to-treat-category-of-advanced-head-and-neck-cancer-patients
PDS Biotech Reports 29.5-Month Median Over...
09/18/2025 12:47:28

First combination therapy to report 29.5 months of Median Overall Survival (mOS); Standard of care Keytruda® (pembrolizumab) al...

pds-biotechnology-corp-files-for-mixed-shelf-of-up-to-200m
PDS Biotechnology Corp Files For Mixed She...
08/29/2025 20:13:58

- SEC Filing

pds-biotechnology-reports-median-overall-survival-of-393-months-in-hpv16-positive-head-and-neck-cancer-patients
PDS Biotechnology Reports Median Overall S...
08/25/2025 12:34:21

Median Overall Survival (mOS) of 39.3 months in patients with CPS ≥ 1 – best published result with standard of care pembrolizum...

pds-biotechnology-q2-eps-021-beats-023-estimate
PDS Biotechnology Q2 EPS $(0.21) Beats $(0...
08/13/2025 11:00:56

PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0...

Core News & Articles
Earnings Scheduled For August 13, 2025
08/13/2025 08:32:30

insights-into-pds-biotechnologys-upcoming-earnings
Insights into PDS Biotechnology's Upcoming...
08/12/2025 18:02:36

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/16/2025 21:06:00

pds-biotech-completes-patient-recruitment-in-stage-1-of-trial-of-pds01adc-study-met-criteria-for-expansion-into-stage-2
PDS Biotech Completes Patient Recruitment ...
07/10/2025 12:08:43

hc-wainwright--co-reiterates-buy-on-pds-biotechnology-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on PDS ...
07/01/2025 10:55:19

HC Wainwright & Co. analyst Joseph Pantginis reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and maintains $13 pri...

hc-wainwright--co-reiterates-buy-on-pds-biotechnology-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on PDS ...
06/11/2025 11:00:37

HC Wainwright & Co. analyst Joseph Pantginis reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and maintains $13 pri...

pds-biotechnology-to-host-virtual-ko-event-to-discuss-unmet-need-and-current-treatment-landscape-for-recurrentmetastatic-hpv16-positive-hnscc
PDS Biotechnology To Host Virtual KO) Even...
06/09/2025 12:09:19

Event to Discuss the Changing Landscape of HNSCC in context with the Merck KN-689 study and the Rapidly Increasing Incidences o...

pds-biotechnology-shares-are-trading-lower-the-company-provided-updates-and-survival-data-for-its-versatile-002-trial
PDS Biotechnology shares are trading lower...
06/02/2025 12:49:13

pds-biotech-reports-durable-30-month-median-overall-survival-in-1l-recurrentmetastatic-hnscc-highlights-urgent-need-in-rapidly-rising-hpv16-positive-cases
PDS Biotech Reports Durable 30-Month Media...
06/02/2025 12:09:58

Median overall survival data in first-line recurrent/metastatic (1L r/m) HNSCC remains durable at 30.0 months with additional f...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
05/23/2025 12:08:30

pds-biotechnologys-phase-2-versamune-hpv-with-pembrolizumab-shows-median-overall-survival-of-393-months-in-cps-20-patients-with-recurrentmetastatic-hpv16-positive-head-and-neck-cancer-phase-3-trial-enrolling-data-to-be-discussed-in-upcoming-conference-call-ahead-of-asco-2025-presentation
PDS Biotechnology's Phase 2 Versamune HPV ...
05/22/2025 21:52:00

pds-biotechnology-q1-eps-021-beats-025-estimate
PDS Biotechnology Q1 EPS $(0.21) Beats $(0...
05/14/2025 11:32:17

Core News & Articles
Earnings Scheduled For May 14, 2025
05/14/2025 08:32:23

insights-ahead-pds-biotechnologys-quarterly-earnings
Insights Ahead: PDS Biotechnology's Quarte...
05/13/2025 17:07:00

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION